DCT

1:20-md-02930

In re: Entresto (Sacubitril/Valsartan) Patent Litigation

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

Filed

03/27/20

Cause of ActionPatent Infringement

SectorBiotech

StatusOpen

Patent Owner

Operating Company (W)

PACER

Nature of Suit835 ANDA

Appeals

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Judge	Period	PO Win Rate
Richard G. Andrews	03/15/22 - now	50%
Leonard P. Stark	03/31/20 - 03/15/22	50%

Plaintiff

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings

No Parties

Attorney

Name	Ratings

No Plaintiff Attorneys

No Attorneys

Defendant

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Nanjing Noratech Pharmaceutical Co Ltd	-- -- --
Gerbera Therapeutics Inc	-- -- --

No Parties

Attorney

Name	Ratings
Husch Blackwell LLP	L5 A
Patrick J. Coyne	L5 A
Peter Kinsella	L5 A
Robert D. Bajefsky	L5 A
Heyman Enerio Gattuso & Hirzel LLPLocal	L5 A
Neal S. Cohen	L5 A
Scott E. Holwick	L5 A

No Attorneys